Integra LifeSciences Holdings Corporation (IART)
USD 19.49
(-2.84%)
USD 19.49
(-2.84%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.48 Billion USD | -4.97% |
| 2022 | 1.56 Billion USD | -1.82% |
| 2021 | 1.59 Billion USD | 6.36% |
| 2020 | 1.49 Billion USD | 6.84% |
| 2019 | 1.4 Billion USD | 5.17% |
| 2018 | 1.33 Billion USD | -25.23% |
| 2017 | 1.78 Billion USD | 167.84% |
| 2016 | 665 Million USD | -5.08% |
| 2015 | 700.59 Million USD | 11.87% |
| 2014 | 626.24 Million USD | 59.73% |
| 2013 | 392.05 Million USD | -24.54% |
| 2012 | 519.54 Million USD | -2.39% |
| 2011 | 532.26 Million USD | 80.53% |
| 2010 | 294.84 Million USD | -4.51% |
| 2009 | 308.75 Million USD | -36.99% |
| 2008 | 490 Million USD | 48.48% |
| 2007 | 330 Million USD | 64860.63% |
| 2006 | 508 Thousand USD | -99.57% |
| 2005 | 118.37 Million USD | -0.44% |
| 2004 | 118.9 Million USD | -0.3% |
| 2003 | 119.25 Million USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | -100.0% |
| 2000 | 4.75 Million USD | -37.39% |
| 1999 | 7.6 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 170.08 Million USD | -9.69% |
| 2024 Q2 | 1.8 Billion USD | 34.3% |
| 2024 Q3 | 1.3 Billion USD | -33.09% |
| 2023 Q2 | 1.49 Billion USD | 61.22% |
| 2023 Q4 | 1.48 Billion USD | 45.86% |
| 2023 Q1 | 926.05 Million USD | -40.74% |
| 2023 FY | 1.48 Billion USD | -4.97% |
| 2023 Q3 | 1.01 Billion USD | -31.81% |
| 2022 FY | 1.56 Billion USD | -1.82% |
| 2022 Q2 | 1.65 Billion USD | 3.92% |
| 2022 Q1 | 1.58 Billion USD | -0.11% |
| 2022 Q3 | 1.64 Billion USD | -0.45% |
| 2022 Q4 | 1.56 Billion USD | -4.99% |
| 2021 Q3 | 1.59 Billion USD | 0.01% |
| 2021 Q2 | 1.59 Billion USD | 0.85% |
| 2021 FY | 1.59 Billion USD | 6.36% |
| 2021 Q1 | 1.58 Billion USD | 5.62% |
| 2021 Q4 | 1.59 Billion USD | -0.15% |
| 2020 Q2 | 1.63 Billion USD | -2.22% |
| 2020 Q3 | 1.52 Billion USD | -6.77% |
| 2020 Q4 | 1.49 Billion USD | -2.12% |
| 2020 FY | 1.49 Billion USD | 6.84% |
| 2020 Q1 | 1.67 Billion USD | 19.74% |
| 2019 Q1 | 1.33 Billion USD | -0.05% |
| 2019 Q4 | 1.4 Billion USD | -5.42% |
| 2019 FY | 1.4 Billion USD | 5.17% |
| 2019 Q3 | 1.48 Billion USD | 5.69% |
| 2019 Q2 | 1.4 Billion USD | 5.27% |
| 2018 Q3 | 1.42 Billion USD | -3.76% |
| 2018 FY | 1.33 Billion USD | -25.23% |
| 2018 Q4 | 1.33 Billion USD | -6.28% |
| 2018 Q2 | 1.47 Billion USD | -16.68% |
| 2018 Q1 | 1.77 Billion USD | -0.51% |
| 2017 Q1 | 848.75 Million USD | 27.63% |
| 2017 FY | 1.78 Billion USD | 167.84% |
| 2017 Q4 | 1.78 Billion USD | 54.53% |
| 2017 Q3 | 1.15 Billion USD | 32.87% |
| 2017 Q2 | 867.5 Million USD | 2.21% |
| 2016 Q1 | 712.18 Million USD | 1.65% |
| 2016 Q2 | 684.29 Million USD | -3.92% |
| 2016 FY | 665 Million USD | -5.08% |
| 2016 Q3 | 658.99 Million USD | -3.7% |
| 2016 Q4 | 665 Million USD | 0.91% |
| 2015 Q1 | 611.42 Million USD | -2.37% |
| 2015 FY | 700.59 Million USD | 11.87% |
| 2015 Q3 | 718.79 Million USD | 11.66% |
| 2015 Q2 | 643.73 Million USD | 5.28% |
| 2015 Q4 | 700.59 Million USD | -2.53% |
| 2014 Q2 | 630.97 Million USD | 0.31% |
| 2014 Q3 | 621.09 Million USD | -1.57% |
| 2014 Q4 | 626.24 Million USD | 0.83% |
| 2014 Q1 | 629 Million USD | 60.44% |
| 2014 FY | 626.24 Million USD | 59.73% |
| 2013 Q2 | 543.25 Million USD | 4.19% |
| 2013 FY | 392.05 Million USD | -24.54% |
| 2013 Q4 | 392.05 Million USD | -28.08% |
| 2013 Q3 | 545.14 Million USD | 0.35% |
| 2013 Q1 | 521.38 Million USD | 0.35% |
| 2012 Q2 | 515.94 Million USD | -1.34% |
| 2012 Q3 | 517.73 Million USD | 0.35% |
| 2012 Q4 | 519.54 Million USD | 0.35% |
| 2012 FY | 519.54 Million USD | -2.39% |
| 2012 Q1 | 522.97 Million USD | -1.74% |
| 2011 Q1 | 136.87 Million USD | -53.58% |
| 2011 Q2 | 144.37 Million USD | 5.48% |
| 2011 Q3 | 541.6 Million USD | 275.14% |
| 2011 FY | 532.26 Million USD | 80.53% |
| 2011 Q4 | 532.26 Million USD | -1.72% |
| 2010 Q4 | 294.84 Million USD | -19.45% |
| 2010 FY | 294.84 Million USD | -4.51% |
| 2010 Q3 | 366.01 Million USD | -1.58% |
| 2010 Q2 | 371.9 Million USD | 25.93% |
| 2010 Q1 | 295.31 Million USD | -4.35% |
| 2009 Q3 | 307.22 Million USD | 0.49% |
| 2009 Q2 | 305.71 Million USD | -29.12% |
| 2009 FY | 308.75 Million USD | -36.99% |
| 2009 Q4 | 308.75 Million USD | 0.5% |
| 2009 Q1 | 431.3 Million USD | -11.98% |
| 2008 Q3 | 330 Million USD | 0.0% |
| 2008 Q1 | 330 Million USD | 0.0% |
| 2008 FY | 490 Million USD | 48.48% |
| 2008 Q2 | 330 Million USD | 0.0% |
| 2008 Q4 | 490 Million USD | 48.48% |
| 2007 Q2 | 330 Million USD | 0.0% |
| 2007 FY | 330 Million USD | 64860.63% |
| 2007 Q4 | 330 Million USD | 0.0% |
| 2007 Q3 | 330 Million USD | 0.0% |
| 2007 Q1 | - USD | -100.0% |
| 2006 FY | 508 Thousand USD | -99.57% |
| 2006 Q3 | 4.88 Million USD | -95.86% |
| 2006 Q2 | 118.11 Million USD | -0.05% |
| 2006 Q1 | 118.16 Million USD | -0.18% |
| 2006 Q4 | 508 Thousand USD | -89.61% |
| 2005 Q1 | 118.63 Million USD | -0.23% |
| 2005 FY | 118.37 Million USD | -0.44% |
| 2005 Q4 | 118.37 Million USD | -0.08% |
| 2005 Q3 | 118.46 Million USD | -0.58% |
| 2005 Q2 | 119.15 Million USD | 0.45% |
| 2004 Q1 | 119.74 Million USD | 0.41% |
| 2004 FY | 118.9 Million USD | -0.3% |
| 2004 Q4 | 118.9 Million USD | -0.27% |
| 2004 Q3 | 119.22 Million USD | 0.75% |
| 2004 Q2 | 118.33 Million USD | -1.17% |
| 2003 Q2 | 119.65 Million USD | 14.3% |
| 2003 FY | 119.25 Million USD | 0.0% |
| 2003 Q4 | 119.25 Million USD | -0.55% |
| 2003 Q3 | 119.91 Million USD | 0.22% |
| 2003 Q1 | 104.68 Million USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2001 FY | - USD | -100.0% |
| 2001 Q1 | 3.12 Million USD | -34.41% |
| 2001 Q2 | 2.51 Million USD | -19.45% |
| 2001 Q4 | - USD | 100.0% |
| 2001 Q3 | -4.17 Million USD | -265.99% |
| 2000 Q3 | 6.95 Million USD | -8.25% |
| 2000 Q1 | 8.2 Million USD | 7.95% |
| 2000 FY | 4.75 Million USD | -37.39% |
| 2000 Q4 | 4.75 Million USD | -31.58% |
| 2000 Q2 | 7.57 Million USD | -7.62% |
| 1999 Q1 | 9.5 Million USD | 0.0% |
| 1999 Q2 | 8.9 Million USD | -6.32% |
| 1999 FY | 7.6 Million USD | 0.0% |
| 1999 Q3 | 8.3 Million USD | -6.74% |
| 1999 Q4 | 7.6 Million USD | -8.43% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | -4013.395% |
| BrainsWay Ltd. | 239 Thousand USD | -621246.444% |
| Cerus Corporation | 59.79 Million USD | -2383.474% |
| Envoy Medical, Inc. | 404 Thousand USD | -367478.713% |
| electroCore, Inc. | 537 Thousand USD | -276439.665% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -12375050.0% |
| IceCure Medical Ltd | 376 Thousand USD | -394851.596% |
| Inogen, Inc. | 18.27 Million USD | -8028.177% |
| OrthoPediatrics Corp. | 13.45 Million USD | -10933.643% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -746140.201% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -408181.554% |
| MaxCyte, Inc. | 17.96 Million USD | -8164.333% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -2686062.362% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | -1494.958% |
| PAVmed Inc | 2.96 Million USD | -50069.527% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -23797.94% |
| RxSight, Inc. | 1.21 Million USD | -122527.415% |
| Sight Sciences, Inc. | 31.7 Million USD | -4583.417% |
| SI-BONE, Inc. | 36.06 Million USD | -4017.615% |
| TELA Bio, Inc. | 40.51 Million USD | -3565.354% |
| Treace Medical Concepts, Inc. | 53 Million USD | -2701.498% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -97534.32% |
| Acutus Medical, Inc. | 32.65 Million USD | -4447.737% |
| Talis Biomedical Corporation | 16.78 Million USD | -8746.765% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -36612.435% |
| CVRx, Inc. | 30.38 Million USD | -4787.822% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -145929.52% |
| Bioventus Inc. | 366.99 Million USD | -304.639% |
| Venus Concept Inc. | 70.79 Million USD | -1997.779% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -119274.437% |
| LivaNova PLC | 568.54 Million USD | -161.197% |
| 908 Devices Inc. | 3.92 Million USD | -37696.335% |
| Alphatec Holdings, Inc. | 511.03 Million USD | -190.59% |
| Nemaura Medical Inc. | 3.08 Million USD | -47995.397% |
| NeuroPace, Inc. | 56.95 Million USD | -2507.399% |
| LENSAR, Inc. | 1.75 Million USD | -84758.171% |
| Apyx Medical Corporation | 33.18 Million USD | -4374.968% |
| Cutera, Inc. | 418.69 Million USD | -254.678% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -9771.165% |
| BioSig Technologies, Inc. | 103 Thousand USD | -1441665.049% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -5419.692% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -14826.304% |
| Axonics, Inc. | 25.84 Million USD | -5646.974% |
| Outset Medical, Inc. | 134.59 Million USD | -1003.323% |
| IRIDEX Corporation | 1.75 Million USD | -84709.709% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | -2792.573% |
| IRadimed Corporation | 1.61 Million USD | -91847.024% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -843660.227% |
| INVO Bioscience, Inc. | 6.77 Million USD | -21815.569% |
| Telesis Bio, Inc. | 5.26 Million USD | -28084.058% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -24769.295% |
| Varex Imaging Corporation | 464.2 Million USD | -219.909% |
| Quipt Home Medical Corp. | 60.82 Million USD | -2341.617% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -252454.082% |
| Pulmonx Corporation | 35.08 Million USD | -4132.147% |
| Dynatronics Corporation | 3.25 Million USD | -45473.977% |
| Modular Medical, Inc. | 817 Thousand USD | -181664.749% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -983355.629% |
| Semler Scientific, Inc. | 70 Thousand USD | -2121354.286% |
| InMode Ltd. | 6.61 Million USD | -22356.041% |
| Bruker Corporation | 1.14 Billion USD | -29.753% |
| Cytosorbents Corporation | 2.54 Million USD | -58299.588% |
| DexCom, Inc. | 2.57 Billion USD | 42.282% |
| Align Technology, Inc. | 96.96 Million USD | -1431.452% |
| Viveve Medical, Inc. | 5.12 Million USD | -28881.616% |
| ZimVie Inc. | 508.79 Million USD | -191.868% |
| Movano Inc. | 15.00 USD | -9900119900.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -8093.203% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | -272.552% |
| Profound Medical Corp. | 4.97 Million USD | -29753.1% |
| Insulet Corporation | 1.36 Billion USD | -8.681% |
| enVVeno Medical Corporation | 1.06 Million USD | -139469.361% |
| Surmodics, Inc. | 29.4 Million USD | -4950.223% |
| iCAD, Inc. | 273 Thousand USD | -543862.637% |
| Nuwellis, Inc. | 221 Thousand USD | -671853.846% |
| Biotricity, Inc. | 10.85 Million USD | -13579.448% |
| iRhythm Technologies, Inc. | 34.95 Million USD | -4148.979% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -228451.861% |
| InspireMD, Inc. | 1.03 Million USD | -142965.318% |
| PAVmed Inc. | 2.96 Million USD | -50069.527% |
| BIOLASE, Inc. | 13.98 Million USD | -10518.649% |
| Beyond Air, Inc. | 14.72 Million USD | -9987.752% |
| FONAR Corporation | 37.92 Million USD | -3815.215% |
| AxoGen, Inc. | 46.6 Million USD | -3086.529% |
| Vivani Medical, Inc. | 19.31 Million USD | -7589.215% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | -3228.741% |
| Inari Medical, Inc. | 30.35 Million USD | -4792.169% |
| UFP Technologies, Inc. | 28 Million USD | -5203.636% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -342034.571% |
| Tenon Medical, Inc. | 428 Thousand USD | -346866.822% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -148105.389% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -68900.641% |
| AdaptHealth Corp. | 2.09 Billion USD | 29.103% |
| Sintx Technologies, Inc. | 3.68 Million USD | -40177.136% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | -3889.517% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -252454.082% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -249064.094% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | -66.436% |
| TransMedics Group, Inc. | 506.2 Million USD | -193.364% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -244548.764% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -1605585.246% |
| Hyperfine, Inc. | 64 Thousand USD | -2320240.625% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | -686.81% |
| Biomerica, Inc. | 459 Thousand USD | -323433.333% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -330283.574% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -781541.902% |
| Silk Road Medical, Inc | 75.62 Million USD | -1863.634% |